Results 191 to 200 of about 497,856 (261)
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Author Correction: Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy. [PDF]
Wang H +13 more
europepmc +1 more source
PANoptosis in the pathogenesis of myelodysplastic syndromes
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla +4 more
wiley +1 more source
Mechanosensing in vascular health and disease. [PDF]
Schwartz MA, Del Pozo MA.
europepmc +1 more source
Spatial biology in cancer epigenetics
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley +1 more source
Editorial: Epigenetic modulation in cancer. [PDF]
Tricarico R, Mondal P, Cortellino S.
europepmc +1 more source
LCR-modules: a collection of workflows for cancer genome analysis. [PDF]
Dreval K +17 more
europepmc +1 more source
Correction: Jannus et al. A Diamine-PEGylated Oleanolic Acid Derivative Induced Efficient Apoptosis through a Death Receptor and Mitochondrial Apoptotic Pathway in HepG2 Human Hepatoma Cells. <i>Biomolecules</i> 2020, <i>10</i>, 1375. [PDF]
Jannus F +7 more
europepmc +1 more source

